Levosimendan in High Risk Patients Undergoing Cardiac Surgery
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Low cardiac output syndrome (LCOs) is a serious complication in critically ill patients or
those undergoing major surgery, resulting in multiple organ damage with significant
in-hospital and long-term morbidity and mortality, as well as prolonged hospital stay. In
this setting the mortality rate is distressingly high despite improvements in intensive care
treatment, but survivors have an acceptable quality of life.